Millennium Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $446K | Sell |
|
|||||
|
2025
Q1 | $1.38M | Buy |
|
|||||
|
2024
Q4 | $1.83M | Sell |
|
|||||
|
2024
Q3 | $5.62M | Sell |
|
|||||
|
2024
Q2 | $14.5M | Buy |
|
|||||
|
2024
Q1 | $15.2M | Buy |
|
|||||
|
2023
Q4 | $10.3M | Sell |
|
|||||
|
2023
Q3 | $5.68M | Buy |
|
|||||
|
2023
Q2 | $4.65M | Sell |
|
|||||
|
2023
Q1 | $5.84M | Buy |
|
|||||
|
2022
Q4 | $13.9M | Buy |
|
|||||
|
2022
Q3 | $11.5M | Sell |
|
|||||
|
2022
Q2 | $17.2M | Buy |
|
|||||
|
2022
Q1 | $5.79M | Buy |
|
|||||
|
2021
Q4 | $1.67M | Sell |
|
|||||
|
2021
Q3 | $5.63M | Buy |
|
|||||
|
2021
Q2 | $6.7M | Sell |
|
|||||
|
2021
Q1 | $9.05M | Buy |
|
|||||
|
2020
Q4 | $3.62M | Sell |
|
|||||
|
2020
Q3 | $9.89K | Sell |
|
|||||
|
2020
Q2 | $27.1M | Buy |
|
|||||
|
2020
Q1 | $2.69M | Sell |
|
|||||
|
2019
Q4 | $15.4M | Buy |
|
|||||
|
2019
Q3 | $3M | Sell |
|
|||||
|
2019
Q2 | $8.08M | Sell |
|
|||||
|
2019
Q1 | $9.96M | Buy |
|
|||||
|
2018
Q4 | $3.8M | Buy |
|
|||||
|
2018
Q3 | $1.42M | Sell |
|
|||||
|
2018
Q2 | $3.4M | Sell |
|
|||||
|
2018
Q1 | $9.73M | Sell |
|
|||||
|
2017
Q4 | $25.5M | Buy |
|
|||||
|
2017
Q3 | $1.67M | Buy |
|
|||||
|
2017
Q2 | $304K | Sell |
|
|||||
|
2017
Q1 | $1.12M | Buy |
|
|||||
|
2016
Q4 | $128K | Sell |
|
|||||
|
2016
Q3 | $1.03M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.89M | Buy |
|
|||||
|
2015
Q4 | $2.15M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $5.41M | Buy |
|
|||||
|
2014
Q4 | $358K | Sell |
|
|||||
|
2014
Q3 | $1.83M | Sell |
|
|||||
|
2014
Q2 | $1.24M | Hold |
|
|||||
|
2014
Q1 | $1.18M | Buy |
|
|||||
|
2013
Q4 | $824K | Buy |
|